What is the primary concern of misbranding?

The primary concern of misbranding is centered around the representations made by the manufacturer regarding a product. Misbranding occurs when a product’s labeling or advertising is misleading or false in any particular way. This includes claims about the product's efficacy, safety, or intended use that do not align with regulatory standards or the actual characteristics of the product. It aims to ensure that consumers are accurately informed about what they are purchasing, allowing them to make safe and informed decisions regarding their health.

Given that misbranding directly addresses how a product is perceived based on the information provided by manufacturers, it does not fundamentally focus on the physical integrity of the drug, legal compliance during manufacturing, or ingredient safety. While these aspects are critical to the overall safety and legality of pharmaceuticals, misbranding is specifically about misleading representations rather than the inherent qualities or compliance status of the product itself.